Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

被引:0
|
作者
Wang, Junyi [1 ]
Cai, Yaning [1 ]
Yu, Fangfang [1 ]
Ping, Zhiguang [1 ]
Liu, Li [2 ]
机构
[1] Zhengzhou Univ, Coll Publ Hlth, 100 Sci Ave, Zhengzhou 450001, Henan, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Body mass index; Metastasis; Breast cancer; Dose-response relationship; Meta-analysis; OBESITY; SURVIVAL; IMPACT; POPULATION; DIAGNOSIS; STAGE; WOMEN; PREMENOPAUSAL; RECURRENCE; ESTROGEN;
D O I
10.1186/s12885-020-07064-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundSince body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis risk of breast cancer.MethodsCohort studies that evaluating BMI and lymph node metastasis in breast cancer were selected through various databases including PubMed, PubMed Central (PMC), Web of science, the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP) and Wanfang Data Knowledge Service Platform (WanFang) until November 30, 2019. The two-stage, random effect meta-analysis was performed to assess the dose-response relationship between BMI and lymph node metastasis risk. Between-study heterogeneity was assessed using I-2. Subgroup analysis was done to find possible sources of heterogeneity.ResultsWe included a total of 20 studies enrolling 52,904 participants. The summary relative risk (RR) (1.10, 95%CI: 1.06-1.15) suggested a significant effect of BMI on the lymph node metastasis risk of breast cancer. The dose-response meta-analysis (RR= 1.01, 95%CI: 1.00-1.01) indicated a positive linear association between BMI and lymph node metastasis risk. For every 1kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.89%. In subgroup analyses, positive linear dose-response relationships between BMI and lymph node metastasis risk were observed among Asian, European, American, premenopausal, postmenopausal, study period less than 5years, and more than 5years groups. For every 1kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.99, 0.85, 0.61, 1.44, 1.45, 2.22, and 0.61%, respectively.ConclusionBMI significantly increases the lymph node metastasis risk of breast cancer as linear dose-response reaction. Further studies are needed to identify this association.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
    Junyi Wang
    Yaning Cai
    Fangfang Yu
    Zhiguang Ping
    Li Liu
    BMC Cancer, 20
  • [2] Paper Body mass index increases the recurrence risk of breast cancer: a dose-response meta-analysis from 21 prospective cohort studies
    Guo, Z.
    Wang, J.
    Tian, X.
    Fang, Z.
    Gao, Y.
    Ping, Z.
    Liu, L.
    PUBLIC HEALTH, 2022, 210 : 26 - 33
  • [3] Body Mass Index and Risk of Breast Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies
    Xia, Xiaoping
    Chen, Wei
    Li, Jiaoyuan
    Chen, Xueqin
    Rui, Rui
    Liu, Cheng
    Sun, Yu
    Liu, Li
    Gong, Jing
    Yuan, Peng
    SCIENTIFIC REPORTS, 2014, 4
  • [4] Body Mass Index and Risk of Breast Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies
    Xiaoping Xia
    Wei Chen
    Jiaoyuan Li
    Xueqin Chen
    Rui Rui
    Cheng Liu
    Yu Sun
    Li Liu
    Jing Gong
    Peng Yuan
    Scientific Reports, 4
  • [5] Body mass index and risk of renal cell cancer: A dose-response meta-analysis of published cohort studies
    Wang, Furan
    Xu, Yinghua
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (07) : 1673 - 1686
  • [6] Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies
    Zhao, Limin
    Tian, Xiaoqin
    Duan, Xueyan
    Ye, Yongxiu
    Sun, Min
    Huang, Junfang
    ONCOTARGET, 2017, 8 (20) : 33990 - 34000
  • [7] Body mass index and cancer risk in patients with type 2 diabetes: a dose-response meta-analysis of cohort studies
    Soltani, Sepideh
    Abdollahi, Shima
    Aune, Dagfinn
    Jayedi, Ahmad
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies
    Xie, Bo
    Zhang, Guanjun
    Wang, Xiao
    Xu, Xin
    ONCOTARGET, 2017, 8 (57) : 97584 - 97592
  • [9] Does body mass index correlate with the mortality of prostate cancer? A dose-response meta-analysis of cohort studies
    Jiang, Wubin
    Chen, Baikang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 88 - 96
  • [10] Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis
    Liu, Kang
    Zhang, Weining
    Dai, Zhiming
    Wang, Meng
    Tian, Tian
    Liu, Xinghan
    Kang, Huafeng
    Guan, Haitao
    Zhang, Shuqun
    Dai, Zhijun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 143 - 150